These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22525081)

  • 1. Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration.
    Bacon R; Newman S; Rankin L; Pitcairn G; Whiting R
    Int J Pharm; 2012 Jul; 431(1-2):39-44. PubMed ID: 22525081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel formulation of ketorolac tromethamine for intranasal administration: preclinical safety evaluation.
    Boyer KC; McDonald P; Zoetis T
    Int J Toxicol; 2010; 29(5):467-78. PubMed ID: 20884857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent patients.
    Drover DR; Hammer GB; Anderson BJ
    Anesth Analg; 2012 Jun; 114(6):1270-6. PubMed ID: 22467894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPRIX (ketorolac tromethamine) nasal spray: a novel nonopioid alternative for managing moderate to moderately severe dental pain.
    Snyder MB; Bregmen DB
    Compend Contin Educ Dent; 2012 Feb; 33 Spec No 1(1):2-11. PubMed ID: 22428363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal ketorolac (Sprix).
    Med Lett Drugs Ther; 2012 Jan; 54(1382):7-8. PubMed ID: 22267216
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of intranasal ketorolac tromethamine pharmacokinetics in younger and older adults.
    Bullingham R; Juan A
    Drugs Aging; 2012 Nov; 29(11):899-904. PubMed ID: 23143939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of nasal formulations of ketorolac.
    Quadir M; Zia H; Needham TE
    Drug Deliv; 2000; 7(4):223-9. PubMed ID: 11195429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
    Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
    Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.
    Djupesland PG; Skretting A
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):280-9. PubMed ID: 22251061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of ketorolac tromethamine after intramuscular and sublingual administration.
    Pérez-Urizar J; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2002; 45():6-7. PubMed ID: 12434509
    [No Abstract]   [Full Text] [Related]  

  • 11. Ketorolac tromethamine formulations: an overview.
    Sinha VR; Kumar RV; Singh G
    Expert Opin Drug Deliv; 2009 Sep; 6(9):961-75. PubMed ID: 19663721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult Subjects.
    Burdick M; Mamelok R; Hurliman M; Dupuis M; Xie Y; Grenier J; Sheldon C; Gartner M; Noymer P
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):343-349. PubMed ID: 27739232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal distribution of budesonide inhaled via a powder inhaler.
    Thorsson L; Newman SP; Weisz A; Trofast E; Morén F
    Rhinology; 1993 Mar; 31(1):7-10. PubMed ID: 8321983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management With an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both.
    Pollack CV; Diercks DB; Thomas SH; Shapiro NI; Fanikos J; Mace SE; Rafique Z; Todd KH
    Acad Emerg Med; 2016 Mar; 23(3):331-41. PubMed ID: 26782787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers.
    McAleer SD; Majid O; Venables E; Polack T; Sheikh MS
    J Clin Pharmacol; 2007 Jan; 47(1):13-8. PubMed ID: 17192497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels.
    Li X; Du L; Chen X; Ge P; Wang Y; Fu Y; Sun H; Jiang Q; Jin Y
    Int J Pharm; 2015 Jul; 489(1-2):252-60. PubMed ID: 25957699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
    Li C; Li C; Liu Z; Li Q; Yan X; Liu Y; Lu W
    Int J Pharm; 2014 Oct; 474(1-2):123-33. PubMed ID: 25138250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
    Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
    J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal ketorolac for acute postoperative pain.
    Singla N; Singla S; Minkowitz HS; Moodie J; Brown C
    Curr Med Res Opin; 2010 Aug; 26(8):1915-23. PubMed ID: 20557145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model.
    Gordon SM; Brahim JS; Rowan J; Kent A; Dionne RA
    Clin Pharmacol Ther; 2002 Aug; 72(2):175-83. PubMed ID: 12189364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.